{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:07:01Z","timestamp":1794352021755,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12282-026-01866-z","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:58:46Z","timestamp":1780048726000},"page":"896-904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of serum microRNA-9-5p expression and its predicted target genes as potential biomarkers for breast cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Mahsa","family":"Najari Nabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Asgari Oskoei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Mohammad Bagheri Parvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Taghizadeh-Teymorloei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-4209","authenticated-orcid":false,"given":"Mehdi","family":"Haghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"2","key":"1866_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77\u2013106.","journal-title":"Genes Dis"},{"key":"1866_CR2","doi-asserted-by":"publisher","first-page":"632079","DOI":"10.3389\/fphar.2020.632079","volume":"11","author":"M Zubair","year":"2021","unstructured":"Zubair M, Wang S, Ali N. Advanced approaches to breast cancer classification and diagnosis. Front Pharmacol. 2021;11:632079.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1866_CR3","first-page":"4736091","volume":"2020","author":"N Tuasha","year":"2020","unstructured":"Tuasha N, Petros B. Heterogeneity of tumors in breast cancer: implications and prospects for prognosis and therapeutics. Scientifica. 2020;2020(1):4736091.","journal-title":"Scientifica"},{"issue":"7","key":"1866_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers17071102","volume":"17","author":"E Carvalho","year":"2025","unstructured":"Carvalho E, Canberk S, Schmitt F, Vale N. Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies. Cancers. 2025;17(7):1102.","journal-title":"Cancers"},{"key":"1866_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","volume":"49","author":"FK Al-Thoubaity","year":"2020","unstructured":"Al-Thoubaity FK. Molecular classification of breast cancer: A retrospective cohort study. Annals Med Surg. 2020;49:44\u20138.","journal-title":"Annals Med Surg"},{"issue":"6586","key":"1866_CR6","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, et al. Early detection of cancer. Science. 2022;375(6586):eaay9040.","journal-title":"Science"},{"issue":"1","key":"1866_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.maturitas.2004.04.011","volume":"49","author":"J Russo","year":"2004","unstructured":"Russo J, Russo IH. Development of the human breast. Maturitas. 2004;49(1):2\u201315.","journal-title":"Maturitas"},{"issue":"4","key":"1866_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.21037\/gs-2025-11","volume":"14","author":"J Venkataraman","year":"2025","unstructured":"Venkataraman J, Crook T, Mokbel K. Liquid biopsy in breast cancer: a practical guide for surgeons. Gland Surg. 2025;14(4):754.","journal-title":"Gland Surg"},{"issue":"1","key":"1866_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12885-024-12180-2","volume":"24","author":"M Taghizadeh","year":"2024","unstructured":"Taghizadeh M, Jafari-Koshki T, Jafarlou V, Raeisi M, Alizadeh L, Roosta Y, et al. The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis). BMC Cancer. 2024;24(1):484.","journal-title":"BMC Cancer"},{"key":"1866_CR10","doi-asserted-by":"crossref","unstructured":"Taghizadeh-Teymorloei M, Jafarlou V, Matin S, Raeisi M, Roosta Y, Mansouri-Derakhshani S et al. Clinical implications of Alu-based cell-free DNA and serum onco-piRNA monitoring in colorectal cancer management. Clin Transl Oncol. 2025:1\u20139.","DOI":"10.1007\/s12094-025-04103-9"},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"1398062","DOI":"10.3389\/fonc.2024.1398062","volume":"14","author":"M Taghizadeh-Teymorloei","year":"2024","unstructured":"Taghizadeh-Teymorloei M, Alizadeh L, Matin S, Jafari-Koshki T, Karimi A. Diagnostic and prognostic significance of ALU-based cell-free DNA in colorectal cancer: a systematic review and meta-analysis. Front Oncol. 2024;14:1398062.","journal-title":"Front Oncol"},{"issue":"1","key":"1866_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-016-0893-x","volume":"14","author":"LF Gulyaeva","year":"2016","unstructured":"Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression. J translational Med. 2016;14(1):143.","journal-title":"J translational Med"},{"key":"1866_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s12672-025-03032-x","volume":"16","author":"G Zhang","year":"2025","unstructured":"Zhang G, Lei S, Zhang K. The effect of microRNA-145 on proliferation and apoptosis of cutaneous squamous cell carcinoma cells. Discover Oncol. 2025;16:1201.","journal-title":"Discover Oncol"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","volume":"28","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty C, Sharma AR, Sharma G, Lee S-S. Therapeutic advances of miRNAs: A preclinical and clinical update. J Adv Res. 2021;28:127\u201338.","journal-title":"J Adv Res"},{"issue":"10","key":"1866_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrd3179","volume":"9","author":"R Garzon","year":"2010","unstructured":"Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discovery. 2010;9(10):775\u201389.","journal-title":"Nat Rev Drug Discovery"},{"issue":"19","key":"1866_CR16","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3390\/diagnostics13193072","volume":"13","author":"JP Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz JP, P\u00e9rez-Moreno P, P\u00e9rez Y, Calaf GM. The role of MicroRNAs in breast cancer and the challenges of their clinical application. Diagnostics. 2023;13(19):3072.","journal-title":"Diagnostics"},{"issue":"1","key":"1866_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12672-025-02744-4","volume":"16","author":"M Parvizi","year":"2025","unstructured":"Parvizi M, Vaezi M, Jeddi F, Bakhshandeh M, Eghdam-Zamiri R, Mobaraki-Asl N, et al. The role and diagnostic value of deregulated miRNAs in cervical cancer. Discover Oncol. 2025;16(1):922.","journal-title":"Discover Oncol"},{"issue":"D1","key":"1866_CR18","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1866_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2199-9-76","volume":"9","author":"PA Davoren","year":"2008","unstructured":"Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008;9:76.","journal-title":"BMC Mol Biol"},{"issue":"1","key":"1866_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nrclinonc.2011.177","volume":"9","author":"CL Arteaga","year":"2012","unstructured":"Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat reviews Clin Oncol. 2012;9(1):16\u201332.","journal-title":"Nat reviews Clin Oncol"},{"issue":"9","key":"1866_CR21","doi-asserted-by":"publisher","first-page":"14651","DOI":"10.1002\/jcp.28210","volume":"234","author":"M Khafaei","year":"2019","unstructured":"Khafaei M, Rezaie E, Mohammadi A, Shahnazi Gerdehsang P, Ghavidel S, Kadkhoda S, et al. miR-9: From function to therapeutic potential in cancer. J Cell Physiol. 2019;234(9):14651\u201365.","journal-title":"J Cell Physiol"},{"issue":"2","key":"1866_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/mco.2020.2193","volume":"14","author":"JY Jang","year":"2021","unstructured":"Jang JY, Kim YS, Kang KN, Kim KH, Park YJ, Kim CW. Multiple microRNAs as biomarkers for early breast cancer diagnosis. Mol Clin Oncol. 2021;14(2):31.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"1866_CR23","doi-asserted-by":"publisher","first-page":"20135","DOI":"10.1038\/s41598-022-24347-7","volume":"12","author":"Z Sharifi","year":"2022","unstructured":"Sharifi Z, Talkhabi M, Taleahmad S. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis. Sci Rep. 2022;12(1):20135.","journal-title":"Sci Rep"},{"key":"1866_CR24","doi-asserted-by":"publisher","first-page":"1482927","DOI":"10.3389\/fgene.2024.1482927","volume":"15","author":"Y Jing","year":"2024","unstructured":"Jing Y, Huang X, Wang Y, Wang J, Li Y, Yelihamu D, Guo C. Diagnostic value of 5 miRNAs combined detection for breast cancer. Front Genet. 2024;15:1482927.","journal-title":"Front Genet"},{"issue":"1","key":"1866_CR25","doi-asserted-by":"publisher","first-page":"45283","DOI":"10.1038\/srep45283","volume":"7","author":"R Barbano","year":"2017","unstructured":"Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, et al. Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients. Sci Rep. 2017;7(1):45283.","journal-title":"Sci Rep"},{"issue":"5","key":"1866_CR26","first-page":"6815","volume":"16","author":"F Guo","year":"2018","unstructured":"Guo F, Hou X, Sun Q. MicroRNA\u20139\u20135p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF. Oncol Lett. 2018;16(5):6815\u201321.","journal-title":"Oncol Lett"},{"key":"1866_CR27","doi-asserted-by":"publisher","first-page":"579160","DOI":"10.3389\/fcell.2020.579160","volume":"8","author":"E Bandini","year":"2020","unstructured":"Bandini E, Fanini F, Vannini I, Rossi T, Plousiou M, Tumedei MM, et al. miR-9-5p as a regulator of the androgen receptor pathway in breast cancer cell lines. Front cell Dev biology. 2020;8:579160.","journal-title":"Front cell Dev biology"},{"key":"1866_CR28","doi-asserted-by":"crossref","unstructured":"Gray JS, Campbell MJ. Challenges and Opportunities of Genomic Approaches in Therapeutics Development. Translational Bioinformatics for Therapeutic Development. 2020:107\u2009\u2013\u200926.","DOI":"10.1007\/978-1-0716-0849-4_7"},{"issue":"22","key":"1866_CR29","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.3390\/ijms232214257","volume":"23","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee S-Y, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22):14257.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1866_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","volume":"19","author":"DL Krebs","year":"2001","unstructured":"Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19(5):378\u201387.","journal-title":"Stem Cells"},{"issue":"4","key":"1866_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/jir.2015.0054","volume":"36","author":"A Rani","year":"2016","unstructured":"Rani A, Murphy JJ. STAT5 in cancer and immunity. J Interferon Cytokine Res. 2016;36(4):226\u201337.","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"1866_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1006\/jmbi.2000.4107","volume":"302","author":"K Phillips","year":"2000","unstructured":"Phillips K, Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J Mol Biol. 2000;302(5):1023\u201339.","journal-title":"J Mol Biol"},{"issue":"3","key":"1866_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/ncrna7030047","volume":"7","author":"M Lange","year":"2021","unstructured":"Lange M, Begolli R, Giakountis A. Non-coding variants in cancer: mechanistic insights and clinical potential for personalized medicine. Non-coding RNA. 2021;7(3):47.","journal-title":"Non-coding RNA"},{"issue":"6","key":"1866_CR34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.modgep.2005.04.001","volume":"5","author":"R Toyoda","year":"2005","unstructured":"Toyoda R, Nakamura H, Watanabe Y. Identification of protogenin, a novel immunoglobulin superfamily gene expressed during early chick embryogenesis. Gene Expr Patterns. 2005;5(6):778\u201385.","journal-title":"Gene Expr Patterns"},{"issue":"1","key":"1866_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/biology2010107","volume":"2","author":"E Di Zazzo","year":"2013","unstructured":"Di Zazzo E, De Rosa C, Abbondanza C, Moncharmont B. PRDM proteins: molecular mechanisms in signal transduction and transcriptional regulation. Biology. 2013;2(1):107\u201341.","journal-title":"Biology"},{"key":"1866_CR36","doi-asserted-by":"crossref","unstructured":"Bansal MP. Redox Regulation and Therapeutic Approaches in Cancer. Springer; 2023.","DOI":"10.1007\/978-981-99-7342-2"},{"issue":"1","key":"1866_CR37","doi-asserted-by":"publisher","first-page":"C80","DOI":"10.1152\/ajpcell.00232.2016","volume":"313","author":"X Li","year":"2017","unstructured":"Li X, He L, Yue Q, Lu J, Kang N, Xu X, et al. MiR-9-5p promotes MSC migration by activating \u03b2-catenin signaling pathway. Am J Physiology-Cell Physiol. 2017;313(1):C80\u201393.","journal-title":"Am J Physiology-Cell Physiol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01866-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01866-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01866-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:22:21Z","timestamp":1781947341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01866-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01866-z","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The analysis was conducted under ethical approval IR.IAU.TABRIZ.REC.1402.098. Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}